Corvia

formerly Corvia Medical

Treatment for Symptomatic Heart Failure | Corvia® Atrial Shunt

Tewksbury, United States · Founded 2009 · $144.0M raised

Employees
11–50
Founded
2009
Business Model
B2B
Total Funding
$144.0M
Last Round
$55.0M Series FJun 2025
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 6 investors for this company. The full record is or through the API.

About

Corvia Medical, Inc. is revolutionizing the treatment of heart failure through novel transcatheter cardiovascular devices. Founded in 2009 and headquartered in Tewksbury, MA, the privately-held company is dedicated to transforming the standard of care for heart failure. Its lead product, the Corvia Atrial Shunt, is a transcatheter implant that reduces elevated left atrial pressure -- the primary driver of heart failure symptoms -- by creating a passage between the left and right atria, and has been granted FDA Breakthrough Device designation.

Summary

Corvia is a Life Sciences company based in Tewksbury, United States, founded in 2009. It has raised $144.0M in total across 3 rounds, most recently a $55.0M Series F round in Jun 2025. Investors include J.P. Morgan Life Sciences Private Capital, General Catalyst and Third Rock Ventures.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series FSeries FJun 2025
$55.0M

Sign up to see all 3 events

Funding: Series F through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Zipline

Zipline operates an autonomous delivery service that transports medical supplies, food, and retai...

South San Francisco, United States501–1000Climate Tech, Defense Tech
Series G+Total funding$2.0BMar 2026
PHC

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...

Minato, Japan5001–10000Healthcare, Life Sciences
Private EquityTotal funding$1.9BMar 2021

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Corvia on Indexed.vc
<a href="https://indexed.vc/companies/corvia"><img src="https://indexed.vc/api/badge/company/corvia" alt="Corvia on Indexed.vc" width="260" height="76" /></a>